Revive Counseling Services, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 304 S Wooten St # 563, Sublette, KS 67877 Phone: 620-675-0040 Fax: 844-645-1452 |
News Archive
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
News-Medical speaks to Dr. Natalia Freund about her latest research into COVID-19, and how most people are capable of producing neutralizing antibodies against the virus.
Researchers from Dartmouth's Institute for Quantitative Biomedical Sciences (iQBS), the Center for Integrative Biomedical Sciences, and the Center for Genomic Medicine at the Geisel School of Medicine are studying the unknown causes of premature birth, as part of a $10 million March of Dimes grant awarded to a research collaborative of seven U.S. universities and medical centers.
Fujitsu Laboratories Ltd. and Fujitsu Limited today announced the development of molecular simulation technology for drug discovery that can accurately estimate binding affinity, which represents the degree to which proteins that can cause diseases (target proteins) bind to chemical substances that could become candidate drugs.
Though it's difficult to think about, what we would do in the event of a violent attack has probably crossed most of our minds, especially as the number and scope of these tragic events has risen in recent years.
› Verified 5 days ago